World's Best Scientists 2026 revealed!
Vittorio Pengo

Vittorio Pengo

D-Index & Metrics

Medicine

D-Index
84
Citations
33666
World Ranking
14908
National Ranking
579

Overview

Vittorio Pengo is affiliated with the University of Padua in Italy, contributing extensively to the field of medicine with a focus on cardiology, rheumatology, hematology, and internal medicine. Their research reflects particular expertise in the domains of systemic lupus erythematosus, platelet disorders, atrial fibrillation management, venous thromboembolism, and blood coagulation mechanisms.

The scientist has published 323 papers predominantly in the field of medicine, with subfields including cardiology and cardiovascular medicine (88 publications), rheumatology (65), hematology (53), internal medicine (28), and surgery (22). Their work addresses several main topics:

  • Systemic Lupus Erythematosus Research
  • Platelet Disorders and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Venous Thromboembolism Diagnosis and Management
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Blood Coagulation and Thrombosis Mechanisms
  • Heparin-Induced Thrombocytopenia and Thrombosis

Pengo's research is frequently published in specialized venues including the Journal of Thrombosis and Haemostasis (13 publications), International Journal of Cardiology (7), European Heart Journal (7), Thrombosis Research (6), and Seminars in Thrombosis and Hemostasis (6).

Frequent collaborators in their research include Gentian Denas, Emilia Antonucci, Gualtiero Palareti, María Laura Bertolaccini, and Hannah Cohen, with collaboration counts ranging from 24 to 32 joint works.

Recent significant papers authored or coauthored by Vittorio Pengo include:

  • Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis, 2020, Journal of Thrombosis and Haemostasis
  • 2023 ACR/EULAR antiphospholipid syndrome classification criteria, 2023, Annals of the Rheumatic Diseases
  • The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, 2023, Arthritis & Rheumatology
  • Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, 2020, Journal of Thrombosis and Haemostasis
  • Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes, 2022, Journal of the American College of Cardiology

Best Publications

  • Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

    Vittorio Pengo;Anthonie W. A. Lensing;Martin H. Prins;Antonio Marchiori

  • Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT)

    Gualtiero Palareti;Nicoletta Leali;Sergio Coccheri;Mario Poggi

  • Update of the guidelines for lupus anticoagulant detection

    Vittorio Pengo;Armando Tripodi;G. Reber;Jacob H. Rand

  • EULAR recommendations for the management of antiphospholipid syndrome in adults

    Maria G Tektonidou;Laura Andreoli;Marteen Limper;Zahir Amoura

  • Chronic Thromboembolic Pulmonary Hypertension

    Nick H. Kim;Marion Delcroix;David P. Jenkins;Richard Channick

  • The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients

    Paolo Prandoni;Franco Noventa;Angelo Ghirarduzzi;Vittorio Pengo

  • d-Dimer Testing to Determine the Duration of Anticoagulation Therapy

    Gualtiero Palareti;Benilde Cosmi;Cristina Legnani;Alberto Tosetto

  • Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.

    Vittorio Pengo;Gentian Denas;Giacomo Zoppellaro;Seena Padayattil Jose

  • Clinical course of high-risk patients diagnosed with antiphospholipid syndrome

    Vittorio Pengo;Amelia Ruffatti;C Legnani;P Gresele

  • Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies

    G. Ruiz-Irastorza;M. J. Cuadrado;I. Ruiz-Arruza;Robin L Brey

  • The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants.

    Perumal Thiagarajan;Vittorio Pengo;Sandor S. Shapiro

  • Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans

    Harumi Takahashi;Grant R Wilkinson;Edith A Nutescu;Takashi Morita

  • PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2

    Sergio Dalla-Volta;Antonio Palla;Annamaria Santolicandro;Carlo Giuntini

  • Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study.

    Vittorio Pengo;Amelia Ruffatti;Cristina Legnani;Sophie Testa

  • Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor: A Systematic Review

    Alfonso Iorio;Clive Kearon;Esmeralda Filippucci;Maura Marcucci

  • Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance

    Maria Gabriella Scordo;Maria Gabriella Scordo;Maria Gabriella Scordo;Vittorio Pengo;Vittorio Pengo;Vittorio Pengo;Edoardo Spina;Edoardo Spina;Edoardo Spina;Marja Liisa Dahl;Marja Liisa Dahl;Marja Liisa Dahl

  • Antibody profiles for the diagnosis of antiphospholipid syndrome.

    Vittorio Pengo;Alessandra Biasiolo;Cinzia Pegoraro;Umberto Cucchini

  • Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation : a randomised, open-label, non-inferiority trial

    M.G. Bousser;J. Bouthier;H.R. Buller;A.T. Cohen

  • The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study.

    B. De Laat;V. Pengo;I. Pabinger;J. Musial

  • Chronic thromboembolic pulmonary hypertension

    Michael Aschermann;Pavel Jansa;David Ambrož;Pavel Poláček

Frequent Co-Authors

Amelia Ruffatti
Amelia Ruffatti University of Padua
Paolo Prandoni
Paolo Prandoni University of Padua
Armando Tripodi
Armando Tripodi University of Milan
Sabino Iliceto
Sabino Iliceto University of Padua
Paolo Gresele
Paolo Gresele University of Perugia
Angela Tincani
Angela Tincani University of Brescia
Munther A. Khamashta
Munther A. Khamashta King's College London
Ricard Cervera
Ricard Cervera University of Barcelona
Walter Ageno
Walter Ageno University of Insubria
Pier Luigi Meroni
Pier Luigi Meroni Istituto Auxologico Italiano

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine doesn't always mean becoming a physician. There are a variety of online degrees and career pathways that can lead to rewarding roles in the healthcare industry. If you're looking for a hands-on patient care position, you might consider what is the easiest nursing school to get into for a more accessible entry route into nursing programs.

Not all students wish to take traditional entrance exams. If that's your case, you can explore nursing schools that don't require teas or hesi, which can help simplify your application process.

For those interested in the administrative or technical side of healthcare, fields like medical billing and coding are in demand and easy to access remotely. Check out the best online medical billing and coding schools to find accredited and flexible options.

Finally, a leadership path may appeal to you. Earn a fast-tracked management degree from one of the healthcare administration degrees available online to quickly advance your career. Each of these pathways provides unique opportunities to make a difference in healthcare.

Best Scientists Citing Vittorio Pengo

Trending Scientists

Recently Published Articles